Arcellx (ACLX) Current Leases (2022 - 2025)
Arcellx (ACLX) recorded quarterly Current Leases of $7.4 million in Q1 2025, up 3100.43% quarter-over-quarter from $230000.0 in Q4 2024, and down 77.37% on a YoY basis from $32.5 million in Q1 2024.
Arcellx (ACLX) Current Leases (2022 - 2025) Analysis & Trends
Arcellx's Current Leases history runs 4 years deep, the most recent figure standing at $7.4 million for Q1 2025.
- In Q1 2025, Current Leases fell 77.37% year-over-year to $7.4 million; the TTM figure through Mar 2025 stood at $7.4 million (down 77.37% YoY), while the FY2024 annual figure was $230000.0, down 96.93% from the prior year.
- Current Leases was $7.4 million for Q1 2025 at Arcellx, up from $230000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $38.0 million in Q2 2023 to a low of $230000.0 in Q4 2024.
- Historically, Current Leases has averaged $14.4 million across 4 years, with a median of $7.4 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Current Leases soared 4942.0% in 2023, then sank 96.93% in 2024.
- A 4-year view of Current Leases shows it stood at $2.9 million in 2022, then jumped by 158.57% to $7.5 million in 2023, then tumbled by 96.93% to $230000.0 in 2024, then jumped by 3100.43% to $7.4 million in 2025.
- The last three Current Leases figures came in at $7.4 million (Q1 2025), $230000.0 (Q4 2024), and $7.3 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 7.36 Mn |
| Dec 31, 2024 | 230,000.00 |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 19.22 Mn |
| Mar 31, 2024 | 32.53 Mn |
| Dec 31, 2023 | 7.50 Mn |
| Sep 30, 2023 | 6.58 Mn |
| Jun 30, 2023 | 38.05 Mn |
| Mar 31, 2023 | 35.29 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Sep 30, 2022 | 27.73 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 700,000.00 |